Development of a high throughput detection system for HIV-1 using real-time NASBA based on molecular beacons

Proceedings of SPIE - The International Society for Optical Engineering

Volumn 4264, Issue , 2001, Pages 66-71

  Van Beuningen, R ^a   Marras, S A ^b   Kramer, F R ^b   Oosterlaken, T ^a   Weusten, J ^a   Borst, G ^a   Van de Wiel, P ^a  

^a Organon Teknika   (Netherlands)

^b Public Health Research Institute   (Netherlands)

Author keywords

HIV 1; Molecular beacon; NASBA; Quantitation; Real time detection

Indexed keywords

CHROMOPHORES; CONFORMATIONS; ENERGY TRANSFER; FLUORESCENCE; RNA;

MOLECULAR BEACONS (MB);

BIOASSAY;

EID: 0034931779     PISSN: 0277786X     EISSN: None     Source Type: Journal    
DOI: 10.1117/12.424591     Document Type: Article

References (30)

1. Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection
2. Serum HIV-1 RNA levels and time to development of AIDS in the Multicenter Hemophilia Cohort Study
3. Changes in plasma HIV-1 RNA and CD4+ lymphocyte counts and the risk of progression to AIDS
4. Long-term effects of antiretroviral combination therapy on HIV Type 1 DNA levels
5. Comparison of levels of human immunodeficiency virus type 1 RNA in plasma as measured by the NucliSens nucleic acid sequence-based amplification and Quantiplex branched-DNA assays
6. Comparison of NucliSens and Roche monitor assays for quantitation of levels of human immunodeficiency virus type 1 RNA in plasma
7. Multicenter comparison of Roche COBAS AMPLICOR MONITOR version 1.5, Organon Teknika NucliSens QT with extractor, and Bayer quantiplex version 3.0 for quantification of human immunodeficiency virus type 1 RNA in plasma
8. Near-full-length genome sequencing of divergent African HIV type 1 subtype F viruses leads to the identification of a new HIV type 1 subtype designated K
9. A compilation and analysis of nucleic and amino acid sequences
10. Human immunodeficiency virus reverse transcriptase and protease sequence database
11. Lower in vivo mutation rate of human immunodeficiency virus type 1 than that predicted from the fidelity of purified reverse transcriptase
12. HIV population dynamics in vivo: Implications for genetic variation, pathogenesis, and therapy
13. Multidrug-resistant human immunodeficiency virus type 1 strains resulting from combination antiretroviral therapy
14. Molecular beacons: Probes that fluoresce upon hybridization
15. Thermodynamic basis of the enhanced specificity of structured DNA probes
16. Detection of factor v Leiden mutation with molecular beacons
17. Molecular beacons - Spectral genotyping of human alleles
18. Molecular beacon probes combined with amplification by NASBA enable homogeneous, real-time detection of RNA
19. Reactivity and amplification efficiency of the NASBA HIV-1 RNA amplification system with regard to different HIV-1 subtypes
20. Use of calibrated viral load standards for group M subtypes of human immunodeficiency virus type 1 to assess the performance of viral RNA quantitation tests
21. A one-tube quantitative HIV-1 RNA NASBA nucleic acid amplification assay using electrochemiluminescent (ECL) labelled probes
22. Quantification of HIV-1 RNA in plasma using NASBATM during HIV-1 primary infection
23. Studies on the base pairing properties of deoxyinosine by solid phase hybridisation to oligonucleotides
24. Rapid and simple method for purification of nucleic acids
25. Automated closed-vessel system for in vitro diagnostics based on polymerase chain reaction
26. Detection of specific polymerase chain reaction product by utilizing the 5′-3′ exonuclease activity of Thermus aquaticus DNA polymerase
27. Detection of PCR products using self-probing amplicons and fluorescence
28. A closed tube format for amplification and detection of DNA based on energy transfer
29. Quantitative and cost comparison of ultrasensitive human immunodeficiency virus type 1 RNA viral load assays: Bayer bDNA quantiplex versions 3.0 and 2.0 and Roche PCR amplicor monitor version 1.5
30. Ultrasensitive reverse transcription-PCR assay for quantitation of human immunodeficiency virus type 1 RNA in plasma